La Guadalupana Salsa Verde Vegan Tamales are packed in a bulk plastic bag inside of a corrugated box and are stored frozen or refrigerate...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2020-2015.
This voluntary recall is being initiated because La Guadalupana's Salsa Verde Vegan Tamales may contain undeclared egg white powder.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2020-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact La Guadalupana Wholesale Co Inc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2020-2015.
La Guadalupana Wholesale Co Inc
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
La Guadalupana Wholesale Co Inc Recall FAQ
La Guadalupana Wholesale Co Inc is the subject of a frozen food safety report: La Guadalupana Salsa Verde Vegan Tamales are packed in a bulk plastic bag inside of a corrugated box and are stored frozen or refrigerate.... The notice was published on April 8, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 85 units are potentially affected.